BioSpace News Archive

Pharm Country

AmerisourceBergen Declares Quarterly Dividend Payable September 3, 2019

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care.

August 8, 2019
·
1 min read
Business

Puma Biotechnology Reports Second Quarter 2019 Financial Results

All comparisons are for the second quarter 2019 compared to the second quarter of 2018.

August 8, 2019
·
14 min read
Drug Development

IMV Inc. Announces Second Quarter 2019 Financial Results and Provides Company Update

Reported positive new data from Phase 2 SPiReL combination study of DPX-Survivac in r/r DLBCL, including long-lasting complete responses

August 8, 2019
·
11 min read
Job Trends

Back to School Is the Time to Get Tested Before Fall Allergy Season Begins

Millions of Americans will soon be impacted by the rise in ragweed and other allergy triggers

August 8, 2019
·
3 min read
Business

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

This innovative agreement forms the nation’s first large-scale physician practice-based infusion program.

August 8, 2019
·
5 min read
Organigram Conditionally Approved to Graduate to the TSX

Conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX under the symbol “OGI.”

August 8, 2019
·
4 min read
Business

BIOLASE Reports Second Quarter 2019 Results

BIOLASE, Inc. reported net revenue of $8.7 million for the second quarter ended June 30, 2019, a decrease of 29% compared to the second quarter of 2018.

August 8, 2019
·
7 min read
Business

BioLife Solutions Announces Second Quarter 2019 Financial Results

BioLife Solutions, Inc., a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, reported financial results and operational highlights for the three and six months ended June 30, 2019.

August 8, 2019
·
10 min read
Business

Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced second quarter 2019 financial results.

August 8, 2019
·
6 min read
Deals

Varian Updates Investors on Proposed Reimbursement Changes

This afternoon, Varian posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for Medicare & Medicaid Services.

August 8, 2019
·
3 min read